Dr. Clark Michael Kardys, MD

Dr. Kardys practices at Texas Oncology PA in San Antonio, Texas.

Dr. Kardys' NPI, 1578763009, was assigned on July 23, 2007. Dr. Kardys graduated from UTMB Health in 2004. Dr. Kardys holds Texas license N9574.

Dr. Kardys' primary practice is Texas Oncology PA, at 7950 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (972) 997-8000.

Dr. Kardys' primary practice is Texas Oncology PA in San Antonio, Texas. Dr. Kardys is also affiliated with Methodist Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Kardys to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kardys practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Kardys' primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Kardys is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Kardys' licenses on file in 3 states: Texas, Kentucky and North Carolina.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Kardys treats.

CMS data shows 185 Medicare services from Dr. Kardys across 6 procedure codes in 2024, for 136 Medicare patients. Medicare paid $13,695 for them.

CMS counts 136 Medicare patients who saw Dr. Kardys in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kardys' median patient age at 60, with 54% women.

In 2024, Dr. Kardys wrote 276 Medicare Part D claims for 91 patients. 97% of them were for generic drugs. CMS names the drug for 212 of them, across 7 drugs with 11 or more claims each, at $2,087 in total drug cost. In 2023, CMS named 124 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kardys for performance year 2024, reported through an alternative payment model (APM). Dr. Kardys accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of colonoscopy by Dr. Kardys, more than 44% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Kardys in 2007. Dr. Kardys' most frequent co-authors are Mark Louis Manwaring, MD and Frank M. Parker, DO.

CMS Open Payments shows 52 general payments to Dr. Kardys from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Intuitive Surgical, Inc. paid the most, $3,772.

Dmand AI lists 2 awards for Dr. Kardys, most recently CMS Stage 1 EHR in 2013.

Dr. Kardys graduated from UTMB Health in 2004. Dr. Kardys is a member of ACS.

Dr. Kardys is in network with 23 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.